Familial (FPAH)
|
0.050 |
Biomarker
|
disease |
BEFREE |
Transfusion studies in patients with familial antithrombin III (ATIII) deficiency: half-disappearance time of infused ATIII and influence of such infusion on platelet life-span.
|
7295588 |
1981 |
Familial (FPAH)
|
0.050 |
Biomarker
|
disease |
BEFREE |
There was no familial deficiency of antithrombin III and plasminogen.
|
6895379 |
1981 |
Thrombosis
|
0.510 |
Biomarker
|
phenotype |
CTD_human |
Estrogen treatment of tall girls: risk of thrombosis?
|
6889048 |
1983 |
Thrombosis
|
0.510 |
Therapeutic
|
phenotype |
CTD_human |
Estrogen treatment of tall girls: risk of thrombosis?
|
6889048 |
1983 |
Cerebral Thrombosis
|
0.310 |
Biomarker
|
disease |
CTD_human |
Changes of the levels of antithrombin III in patients with cerebrovascular diseases.
|
6636041 |
1983 |
Thrombus
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Estrogen treatment of tall girls: risk of thrombosis?
|
6889048 |
1983 |
Thrombus
|
0.300 |
Therapeutic
|
phenotype |
CTD_human |
Estrogen treatment of tall girls: risk of thrombosis?
|
6889048 |
1983 |
Intracranial Thrombosis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Changes of the levels of antithrombin III in patients with cerebrovascular diseases.
|
6636041 |
1983 |
Brain Thrombosis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Changes of the levels of antithrombin III in patients with cerebrovascular diseases.
|
6636041 |
1983 |
Brain Thrombus
|
0.300 |
Biomarker
|
disease |
CTD_human |
Changes of the levels of antithrombin III in patients with cerebrovascular diseases.
|
6636041 |
1983 |
Cerebral Thrombus
|
0.300 |
Biomarker
|
disease |
CTD_human |
Changes of the levels of antithrombin III in patients with cerebrovascular diseases.
|
6636041 |
1983 |
Cerebral Hemorrhage
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Changes of the levels of antithrombin III in patients with cerebrovascular diseases.
|
6636041 |
1983 |
Familial (FPAH)
|
0.050 |
Biomarker
|
disease |
BEFREE |
A familial abnormal antithrombin III (AT-III) is reported.
|
6636045 |
1983 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.
|
6582486 |
1984 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.
|
6582486 |
1984 |
Antithrombin III Deficiency
|
1.000 |
Biomarker
|
disease |
CTD_human |
[Treatment of deep venous thrombosis in the presence of a congenital antithrombin III deficiency. Apropos of the use of purified concentrates].
|
6435583 |
1984 |
Deep Vein Thrombosis
|
0.500 |
Biomarker
|
disease |
CTD_human |
[Treatment of deep venous thrombosis in the presence of a congenital antithrombin III deficiency. Apropos of the use of purified concentrates].
|
6435583 |
1984 |
Venous Thrombosis
|
0.340 |
Biomarker
|
phenotype |
CTD_human |
Before heparinisation, he was discovered to have a low antithrombin III level (biological activity (B) 60%, immunological level (I) 50) and a further inquiry showed the same abnormality in 4 members of the family, leading to a diagnosis of a congenital deficit: a 35 year old sister with a bilateral post-DVT changes had antithrombin III levels of 70% (B) and 45% (I); two nephews, sons of the affected sister: the one aged 5 years was asymptomatic despite antithrombin III levels of 50% (I) and 70% (B); the other had experience DVT at the age of 2 and, on oral anti-vitamin K drugs, had antithrombin III levels of 55% (I) and 67% (B) at the age of 15 years; the patient's brother died at the age of 29 of cerebral vein thrombosis after pulmonary embolism.
|
6435583 |
1984 |
Hereditary Antithrombin Deficiency
|
0.340 |
Biomarker
|
disease |
CTD_human |
[Treatment of deep venous thrombosis in the presence of a congenital antithrombin III deficiency. Apropos of the use of purified concentrates].
|
6435583 |
1984 |
Disseminated Intravascular Coagulation
|
0.330 |
Biomarker
|
disease |
CTD_human |
[Disseminated intravascular coagulation induced by heparin. Treatment with a combination of low-molecular weight heparin and concentrated antithrombin III].
|
6233579 |
1984 |
Disseminated Intravascular Coagulation
|
0.330 |
Therapeutic
|
disease |
CTD_human |
[Disseminated intravascular coagulation induced by heparin. Treatment with a combination of low-molecular weight heparin and concentrated antithrombin III].
|
6233579 |
1984 |
Liver Failure, Acute
|
0.310 |
Biomarker
|
disease |
CTD_human |
Heparin response and clearance in acute and chronic liver disease.
|
4089794 |
1985 |
Antithrombin III Deficiency
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Antithrombin III Basel. Identification of a Pro-Leu substitution in a hereditary abnormal antithrombin with impaired heparin cofactor activity.
|
3080419 |
1986 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Antithrombin III Basel. Identification of a Pro-Leu substitution in a hereditary abnormal antithrombin with impaired heparin cofactor activity.
|
3080419 |
1986 |
Venous Thromboembolism
|
0.400 |
Biomarker
|
phenotype |
BEFREE |
Four members of an Italian family (two with histories of venous thromboembolism) had a qualitative defect of antithrombin III reflected by normal antigen concentrations and half-normal antithrombin activity with or without heparin.
|
3563966 |
1986 |